Fundamental Analysis
19 / 100CRubric: Manufacturing
| Quarterly results | Relative Valuation | |||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Criterion | Latest Q EPS growth (YoY) | Avg EPS growth, last 3 (YoY) | Quarters with EPS growth | Revenue growth (YoY) | Gross margin change (pp, YoY) | Net margin change (pp, YoY) | Return on Equity (TTM) | Financial health (Debt/Equity) | Valuation (P/E vs 5-yr median) | Revenue (bn) | Rev YoY | NPAT (bn) | NPAT YoY | P/E | 5-Year Median P/E | P/E vs. 5-Year Median |
| Value | -50.3% | -51.9% | 1 / 3 | -98.6% | -23.29 pp | -745.87 pp | +0.7% | 0.01 | 96.75 | 0,4 | −98,6% | −3,0 | −50,6% | 96.75 | 15.52 | +523,4% |
| Pts | 0 | 0 | 4 | 0 | 0 | 0 | 0 | 12 | 4 | |||||||
Valuation annotation:Price: 7.700 (close price on 2026-10-19)EPS (TTM): 79,6
Financial charts
1.Revenue & growth
VND bn0,39Q2/26
1.Revenue & growth
VND bn0,39Q2/26
2.Profit & growth
VND bn-3,00Q2/26
3.Profit mix (Penman)
VND bn5,40Q2/26
4.Margins & cost structure
%-9.5%Q2/26
5.Returns & cash cycle
% · days-0.2%Q2/26
6.Earnings quality & cash
VND bn-64,8Q2/26
7.Asset structure
VND bn475Q2/26
8.Funding & debt health
VND bn · times475Q2/26
9.Revenue backlog
VND bn0,00Q2/26
10.Valuation
times · %96,8×Q2/26
11.EPS growth & dilution warning (CANSLIM)
VND per share; growth in %-78Q2/26
Adjusted EPS growth, latest quarter
No comparable quarter a year earlier
Average adjusted EPS growth, 3 quarters
-52.7%
averaged over 2 quarter(s)
Quarters at 25%+ growth
1/3
Share dilution rate, 1 year
0.0%
Source: vnstockData through Q2/26